PALBOCICLIB

93581 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking PALBOCICLIB:

# Side effect Count
0 FATIGUE 15580
1 WHITE BLOOD CELL COUNT DECREASED 11337
2 NEOPLASM PROGRESSION 10628
3 NAUSEA 8459
4 DEATH 7658
5 NEUTROPENIA 6613
6 ALOPECIA 6311
7 DIARRHOEA 5868
8 ASTHENIA 3723
9 OFF LABEL USE 3628
See all common reactions for PALBOCICLIB

PALBOCICLIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOHYDRATE ANTIGEN 27.29 INCREASED 56 0.3810
1 PIK3CA-ACTIVATED MUTATION 102 0.3259
2 BODY SURFACE AREA INCREASED 41 0.3228
3 NEOPLASM PROGRESSION 10628 0.3098
4 CARBOHYDRATE ANTIGEN 15-3 INCREASED 176 0.2391
5 TUMOUR MARKER ABNORMAL 62 0.1914
6 TUMOUR MARKER INCREASED 868 0.1869
7 PSEUDOCIRRHOSIS 46 0.1554
8 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 39 0.1455
9 BASOPHIL PERCENTAGE INCREASED 23 0.1447
See all enriched reactions for PALBOCICLIB